Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018
Tongtong Wang; Yuzhi Xi; Annaswamy Raji; Michael Crutchlow; Gail Fernandes; Samuel S Engel; Xiao Zhang;
Ann Hepatol. 2024;29:
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;
10.1016/j.aohep.2024.101757
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT
Jeremy Lee; Christopher J. Byrne; Paul N. Brennan; Iain MacPherson; Eleanor Dow; John F. Dillon;
Ann Hepatol. 2024;29: